Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Curis Swings To Q4 Profit

RELATED NEWS
Trade CRIS now with 

Curis, Inc. (CRIS: Quote) reported net income for the fourth quarter of $6.1 million or $0.07 per share, compared to a net loss of $5.6 million or $0.07 per share for the year-ago quarter.

Revenues for the fourth quarter surged ti $14.1 million from $100,000 a year ago. The increase is the result of $14.0 million in license fee revenues recorded during the fourth quarter of 2011 for payments that Curis received from Genentech for the achievement of certain regulatory objectives related to Erivedge.

Analysts polled by Thomson Reuters expected the company to earn $0.06 per share on revenue of $10.16 million for the fourth quarter.

Click here to receive FREE breaking news email alerts for Curis Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Reserve Bank of India kept its key rates unchanged once again as expected, citing upside risks to medium-term inflation target. The decision announced Tuesday meant that the repo rate was left unchanged at 8.00 percent for the fourth straight policy meeting. The repo rate is the rate at which the central bank lends to commercial banks. The Reserve Bank of India kept its key rates unchanged once again as expected, citing upside risks to medium-term inflation target. The decision announced Tuesday meant that the repo rate was left unchanged at 8.00 percent for the fourth straight policy meeting. The repo rate is the rate at which the central bank lends to commercial banks. U.K. house prices unexpectedly declined in September after rising for sixteen straight months amid signs that demand may be starting to ease, the results of a survey by the Nationwide Building Society showed Tuesday. The house price index dropped 0.2 percent from August, when it climbed 0.8 percent....
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.